acetyl-l-carnitine hepatic encephalopathy randomized trial

acetyl-l-carnitine hepatic encephalopathy randomized trial Current advances in the management of encephalopathy: an updated and critical review | Pharmacological Reports acetyl-l-carnitine hepatic encephalopathy randomized trial

Name: acetyl-l-carnitine hepatic encephalopathy randomized trial Current advances in the management of encephalopathy: an updated and critical review | Pharmacological Reports acetyl-l-carnitine hepatic encephalopathy randomized trial
Brand: www.fysioparkdokkum.nl
SKU: 12868903889
Price: 29.69 USD
Availability: InStock
Rating: 4.7506 (26 reviews)

SKU: 12868903889

4.8

USD29.69 USD77.69

Pay in 4 interest-free payments of $7.42 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 8 - Sep 13

Description

Under some pathophysiological circumstances, endothelium-derived vasoconstricting factors, such as ET-1, AT-II, urotensin II, superoxide anions, vasoconstrictor prostaglandins and thromboxane A 2 , can be released and contribute to the paradoxical vasoconstrictor effects